300.98USD+1.78%Mkt Cap: 8.05B $P/E: 50.161d ago
Bio-Rad Laboratories, Inc. develops, manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, Latin America, and internationally. It operates throug…
Industry Peers
Medical DevicesIndicators:|
Key Statistics
Company
Market Cap8.05B $
Enterprise Value7.87B $
Revenue (TTM)2.59B $
Gross Profit1.34B $
Net Income (TTM)759.90M $
Revenue/Share95.80 USD
Last Price300.98 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees7.5K
CountryUS
SectorHealthcare
IndustryMedical Devices
ISINUS0905722072
Valuation
P/E (Trailing)50.16
P/E (Forward)30.96
PEG4.01
EV/EBITDA17.69
EV/Revenue3.04
P/S3.11
P/B1.18
EPS (TTM)6.00
EPS (Forward)9.72
52W Range
236.7360% of range343.12
52W High343.12 USD
52W Low236.73 USD
Profitability
Gross Margin51.87%
Oper. Margin5.76%
EBITDA Margin17.17%
Profit Margin29.42%
ROE10.20%
ROA7.18%
Growth
Revenue Growth1.10%
Earnings Growth—
Cash Flow & Leverage
Operating CF532.20M $
CapEx (TTM)157.60M $
FCF Margin8.87%
FCF Yield2.85%
Net Debt-186.50M $
Net Debt/EBITDA-0.42
Balance Sheet
Debt/Equity0.19
Current Ratio3.21
Quick Ratio2.19
Book Value/Sh255.37 USD
Cash/Share58.47 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split2:1
Split DateMar 8, 2002
Analyst Consensus
Rating—
Target (Mean)297.00 USD
Upside (mean)-1.3%
Target Range275.00 USD – 320.00 USD
$275.00-1.3% to mean$320.00
# Analysts5
Ownership
Shares Out.21.70M
Float20.91M
Insiders16.34%
Institutions94.36%
Short Interest
Short Ratio0.0d
Short % Float0.00%
Short % Out.0.00%
Shares Short220
Short (prev mo.)91
Technical
SMA 50285.18 (+5.5%)
SMA 200294.48 (+2.2%)
Beta1.08
S&P 52W Chg20.25%
Avg Vol (30d)280.43K
Avg Vol (10d)261.56K
Technical Indicators
RSI (14)56.8
MACD2.5715
MACD Signal2.0934
MACD Hist.+0.4782
BB Upper308.72 USD
BB Middle291.90 USD
BB Lower275.07 USD
BB Width11.53%
ATR (14)8.861 USD
Vol Ratio (20d)0.83x